Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma, Testicular 1Stomach Neoplasms 1Skin Neoplasms 1Rectal Neoplasms 1Pancreatic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Carboplatin 3Filgrastim 2tislelizumab 1sargramostim 1milademetan 1etoposide phosphate 1aldesleukin 1Topotecan 1Thiotepa 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Nicotine 1Microarray Analysis 1In Situ Hybridization 1Immunologic Techniques 1Immunohistochemistry 1Ifosfamide 1Etoposide 1Dasatinib 1Cyclophosphamide 1Blotting, Western 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Testicular Germ Cell Tumor × In Situ Hybridization × Gastrointestinal × Clear all
NCT00899132 2015-09-29

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Case Comprehensive Cancer Center

Terminated
180 enrolled
DermatologicGastrointestinalGenitourinary

Teratoma, Testicular, Testicular Germ Cell Tumor, Pancreatic Neoplasms, Skin Neoplasms, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡